THE ROLE OF REACTIVE OXYGEN SPECIES IN TUMOR CELLS APOPTOSIS INDUCED BY LANDOMYCIN A
Ukrainian Biochemical Journal
|January 1, 2016
Summary
Landomycin A, an antitumor antibiotic, rapidly increases reactive oxygen species (ROS) in leukemia cells, triggering apoptosis. Antioxidants like catalase and mannitol protect cells, highlighting ROS's role in Landomycin A's anticancer effects.
Area of Science:
- Pharmacology
- Cell Biology
- Biochemistry
Background:
- Landomycin A (LA) is an angucycline antibiotic with potent antitumor activity.
- LA induces early apoptosis in various cancer cells.
- The mechanism of LA-induced cell death involves reactive oxygen species (ROS).
Purpose of the Study:
- To investigate the role of ROS in Landomycin A-mediated cancer cell death.
- To identify the specific ROS involved in LA's cytotoxic effects.
- To evaluate the potential of antioxidants in mitigating LA's toxicity.
Main Methods:
- Human T-leukemia cells were treated with Landomycin A.
- ROS levels were measured using spectrophotometry.
- Apoptosis was assessed by DNA fragmentation and chromatin condensation.
- The effects of ROS scavengers (catalase, mannitol, superoxide dismutase) on cell viability were evaluated.
Main Results:
- Landomycin A treatment increased ROS levels 5.6-fold within 1 hour.
- Apoptotic markers (DNA cleavage, chromatin condensation) appeared by 6 hours.
- Catalase and mannitol significantly reduced ROS and inhibited LA-induced cell death, increasing cell viability 2.5-fold.
- Superoxide dismutase had a minor effect, suggesting superoxide radicals play a limited role.
- Combined antioxidants increased cell viability 4-fold compared to LA alone.
Conclusions:
- ROS, particularly H2O2 and hydroxyl radicals, are key mediators of Landomycin A's antitumor activity.
- Catalase and mannitol can protect cancer cells from LA-induced apoptosis.
- Superoxide radicals are less critical for LA's cytotoxic effects.
- Targeting ROS pathways may enhance the therapeutic efficacy of Landomycin A.
Related Concept Videos
The Intrinsic Apoptotic Pathway
9.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
Electron Transport Chain: Complex I and II
19.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.5K
Apoptosis
16.9K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
16.9K
The Extrinsic Apoptotic Pathway
9.3K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.3K
Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K

